Day One Net Income vs. Shares Owned By Insiders

DAWN Stock  USD 12.69  0.10  0.78%   
Based on the measurements of profitability obtained from Day One's financial statements, Day One Biopharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Day One's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-188.9 M
Current Value
-179.5 M
Quarterly Volatility
63.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Day One's Tangible Book Value Per Share is very stable compared to the past year. As of the 24th of December 2024, Graham Number is likely to grow to 15.97, though Free Cash Flow Yield is likely to grow to (0.12).
For Day One profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Day One to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Day One Biopharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Day One's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Day One Biopharmaceuticals over time as well as its relative position and ranking within its peers.
  

Day One's Revenue Breakdown by Earning Segment

Check out Investing Opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.144
Return On Assets
(0.25)
Return On Equity
(0.18)
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Day One Biopharmaceu Shares Owned By Insiders vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Day One's current stock value. Our valuation model uses many indicators to compare Day One value to that of its competitors to determine the firm's financial worth.
Day One Biopharmaceuticals is rated below average in net income category among its peers. It is rated # 2 in shares owned by insiders category among its peers . Day One reported last year Net Loss of (188.92 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Day One's earnings, one of the primary drivers of an investment's value.

Day Shares Owned By Insiders vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Day One

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(188.92 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Day One

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
16.98 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Day Shares Owned By Insiders Comparison

Day One is currently under evaluation in shares owned by insiders category among its peers.

Day One Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Day One, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Day One will eventually generate negative long term returns. The profitability progress is the general direction of Day One's change in net profit over the period of time. It can combine multiple indicators of Day One, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive IncomeK9.4 K
Net Interest Income5.5 M5.7 M
Operating Income-206.1 M-195.8 M
Net Loss-188.9 M-179.5 M
Income Before Tax-188.9 M-179.5 M
Total Other Income Expense Net17.1 M18 M
Net Loss-128 M-134.4 M
Net Loss-188.9 M-179.5 M
Income Tax Expense-9 M-8.6 M
Interest Income4.3 M4.1 M
Non Operating Income Net Other-13.5 K-14.2 K
Change To Netincome31.3 M20.8 M
Net Loss(2.37)(2.49)
Income Quality 0.78  0.45 
Net Income Per E B T 0.84  0.74 

Day Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Day One. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Day One position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Day One's important profitability drivers and their relationship over time.

Use Day One in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Day One position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will appreciate offsetting losses from the drop in the long position's value.

Day One Pair Trading

Day One Biopharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to Day One could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Day One when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Day One - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Day One Biopharmaceuticals to buy it.
The correlation of Day One is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Day One moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Day One Biopharmaceu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Day One can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Day One position

In addition to having Day One in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Exotic Funds Thematic Idea Now

Exotic Funds
Exotic Funds Theme
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Investing Opportunities.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
To fully project Day One's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Day One Biopharmaceu at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Day One's income statement, its balance sheet, and the statement of cash flows.
Potential Day One investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Day One investors may work on each financial statement separately, they are all related. The changes in Day One's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Day One's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.